This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Randomized Controlled Trial

. 2008 May 24;371(9626):1726-8.

doi: 10.1016/S0140-6736(08)60737-0.

Novel cardiac therapies and innocent by standers

Stephen J Duffy¹, Anthony M Dart

Affiliations

PMID: 18502279
DOI: 10.1016/S0140-6736(08)60737-0

Randomized Controlled Trial

Novel cardiac therapies and innocent by standers

Stephen J Duffy et al. Lancet. 2008.

. 2008 May 24;371(9626):1726-8.

doi: 10.1016/S0140-6736(08)60737-0.

Authors

Stephen J Duffy¹, Anthony M Dart

Affiliation

¹ Department of Cardiovascular Medicine, Alfred Hospital, Melbourne 3004, VIC, Australia. s.duffy@alfred.org.au

PMID: 18502279
DOI: 10.1016/S0140-6736(08)60737-0

No abstract available

PubMed Disclaimer

Comment on

Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial.
Tardif JC, McMurray JJ, Klug E, Small R, Schumi J, Choi J, Cooper J, Scott R, Lewis EF, L'Allier PL, Pfeffer MA; Aggressive Reduction of Inflammation Stops Events (ARISE) Trial Investigators. Tardif JC, et al. Lancet. 2008 May 24;371(9626):1761-8. doi: 10.1016/S0140-6736(08)60763-1. Lancet. 2008. PMID: 18502300 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information